title: Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects.
abstract: Understanding the risks of antipsychotic medication use in pregnancy is becoming an important clinical concern given the evidence of their increasing rate of prescription in the general population for a range of disorders. Despite antipsychotics being amongst the earliest of psychotropic medications to be introduced, the evidence for their effects secondary to pregnancy exposure is extremely limited. While this review does not identify clear evidence for a risk of malformation, there is evidence for risks associated with pregnancy and neonatal outcomes. Studies identified found risks that included prematurity, low and high birth weight, and gestational diabetes. There have also been studies that suggest neonatal withdrawal and abnormal muscles movements. The longer term neurodevelopmental outcomes for children exposed in utero remain unclear with only four studies identified: two of first generation antipsychotics and two of second generation antipsychotics. When considering the risk of these medications in pregnancy, the risk of untreated maternal illness (particularly schizophrenia and bipolar disorder) on both maternal and child outcomes is relevant. Future research needs to focus on prospective, longitudinal studies with adequate measures of key confounding variables including maternal mental illness, other exposures (such as smoking, alcohol and illicit drug use) and adequate length of follow up where accurate child developmental measures are obtained.
authors.affiliation: Perinatal Mental Health, Mercy Hospital for Women, 16 Studley Road, Heidelberg, VIC 3084, Australia.
authors.forename: Megan
authors.initials: M
authors.lastname: Galbally
authors.affiliation: Perinatal Mental Health, Mercy Hospital for Women, Heidelberg, VIC, Australia.
authors.forename: Martien
authors.initials: M
authors.lastname: Snellen
authors.affiliation: Perinatal Mental Health, Mercy Hospital for Women, Heidelberg, VIC, Australia.
authors.forename: Josephine
authors.initials: J
authors.lastname: Power
keywords: antipsychotics; bipolar disorder; pregnancy; schizophrenia
references.citation: J Clin Psychopharmacol. 2010 Jun;30(3):331-2
references.pmid: 20473073
references.citation: Cochrane Database Syst Rev. 2004;(2):CD004411
references.pmid: 15106251
references.citation: Med J Aust. 2007 Apr 2;186(7):364-7
references.pmid: 17407434
references.citation: Arch Gen Psychiatry. 2012 Aug;69(8):787-94
references.pmid: 22474072
references.citation: Arch Womens Ment Health. 2009 Jun;12(3):123-34
references.pmid: 19337701
references.citation: J Clin Psychopharmacol. 2008 Jun;28(3):279-88
references.pmid: 18480684
references.citation: Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):177-84
references.pmid: 21254289
references.citation: Psychopharmacology (Berl). 2013 Aug;228(4):577-84
references.pmid: 23559219
references.citation: Am J Psychiatry. 2007 Dec;164(12):1817-24; quiz 1923
references.pmid: 18056236
references.citation: Neurotoxicol Teratol. 1999 Mar-Apr;21(2):157-67
references.pmid: 10192276
references.citation: Arch Gen Psychiatry. 2012 Jul;69(7):715-21
references.pmid: 22752236
references.citation: Pharm Weekbl Sci. 1990 Dec 14;12(6):252-5
references.pmid: 1982564
references.citation: Am J Psychiatry. 2007 Aug;164(8):1214-20
references.pmid: 17671284
references.citation: Am J Psychiatry. 2005 Jan;162(1):79-91
references.pmid: 15625205
references.citation: Arch Womens Ment Health. 2008 Jul;11(3):171-9
references.pmid: 18493714
references.citation: Br J Psychiatry. 2008 May;192(5):333-7
references.pmid: 18450655
references.citation: Am J Obstet Gynecol. 1977 Jul 1;128(5):486-8
references.pmid: 879206
references.citation: Aust N Z J Psychiatry. 1999 Dec;33(6):902-11
references.pmid: 10619219
references.citation: Schizophr Res. 2010 Jan;116(1):55-60
references.pmid: 19896335
references.citation: Drug Saf. 2007;30(3):247-64
references.pmid: 17343431
references.citation: Aust N Z J Psychiatry. 2010 Feb;44(2):99-108
references.pmid: 20113298
references.citation: BMC Pharmacol Toxicol. 2013 Aug 01;14:38
references.pmid: 23902726
references.citation: Aust N Z J Psychiatry. 2013 Jan;47(1):74-87
references.pmid: 23144164
references.citation: J Psychiatr Pract. 2009 May;15(3):183-92
references.pmid: 19461391
references.citation: Arch Womens Ment Health. 2009 Feb;12(1):53-7
references.pmid: 19137446
references.citation: Arch Gen Psychiatry. 1995 Mar;52(3):189-92
references.pmid: 7872842
references.citation: Curr Opin Obstet Gynecol. 2011 Dec;23(6):408-14
references.pmid: 21897237
references.citation: Br J Psychiatry. 1999 Sep;175:239-45
references.pmid: 10645325
references.citation: Schizophr Bull. 2010 May;36(3):518-44
references.pmid: 18787227
references.citation: Psychol Med. 2007 Apr;37(4):537-46
references.pmid: 17076915
references.citation: Aust N Z J Psychiatry. 2010 Nov;44(11):967-77
references.pmid: 21034180
references.citation: Arch Gen Psychiatry. 1995 Mar;52(3):173-88
references.pmid: 7872841
references.citation: J Clin Psychopharmacol. 2013 Aug;33(4):453-62
references.pmid: 23764684
references.citation: Perspect Sex Reprod Health. 2006 Jun;38(2):90-6
references.pmid: 16772190
references.citation: J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546
references.pmid: 15816786
references.citation: Neurotoxicol Teratol. 1992 Nov-Dec;14(6):399-406
references.pmid: 1488034
references.citation: Br J Psychiatry. 2004 Jul;185:11-7
references.pmid: 15231550
references.citation: Am J Psychiatry. 2011 Nov;168(11):1179-85
references.pmid: 21799064
references.citation: J Affect Disord. 2000 Dec;61(1-2):31-9
references.pmid: 11099738
references.citation: Neurology. 2008 Sep 30;71(14):1109-17
references.pmid: 18703463